Related Experiment Video
Updated: Aug 12, 2026

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
Published on: August 19, 2020
Effect of chloral hydrate on arterial oxygen saturation in wheezy infants
1Professiorial Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
Insights
Sedating infants with chloral hydrate for pulmonary function tests may lower oxygen levels, especially in those with wheezing illnesses. This common practice raises safety concerns for vulnerable infants.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Chloral hydrate is frequently used for infant sedation during pulmonary function tests.
- Current sedation practices may exceed recommended dosages.
- The impact of these doses on infants with acute wheezing is not well-understood.
Purpose of the Study:
- To evaluate the effects of commonly used chloral hydrate doses on sedated infants undergoing pulmonary function testing.
- To assess the safety and efficacy of chloral hydrate in infants with acute viral bronchiolitis versus cystic fibrosis.
Main Methods:
- Infants received 70-100 mg/kg of chloral hydrate for sedation.
- Arterial oxygen saturation (SaO2) and clinical scores were monitored.
- Infants were categorized into groups with acute viral bronchiolitis and stable cystic fibrosis.
Main Results:
- Chloral hydrate sedation led to decreased SaO2 and clinical scores in infants recovering from bronchiolitis.
- No significant adverse effects were observed in infants with stable cystic fibrosis.
- Wheezy infants with baseline SaO2 ≤ 94% showed increased susceptibility to respiratory depression.
Conclusions:
- The standard dose of chloral hydrate may cause respiratory depression in wheezy infants.
- Sedation with chloral hydrate in the studied doses is questionable for infants with acute wheezing illnesses.
- Further research is needed to determine safe sedation protocols for pediatric pulmonary function testing.
Abstract:
Chloral hydrate is commonly used to sedate infants for pulmonary function tests and other investigations. However, sedation is generally not recommended for infants with acute wheezing illnesses. The commonly used dose range exceeds the maximum recommended dose; however, the effects of this dosage regimen during pulmonary function testing have not been studied. The present study shows that 70-100 mg/kg of chloral hydrate, a dose commonly used to sedate infants for pulmonary function testing, causes a fall in arterial oxygen saturation and a decrease in clinical score of infants recovering from acute viral bronchiolitis, but not in infants with clinically stable cystic fibrosis. These findings suggest that wheezy infants with baseline SaO2 less than or equal to 94% are more susceptible to central respiratory depression following sedation with chloral hydrate. The results of the present study raise serious doubts about the advisability of sedation with chloral hydrate, in the currently used doses, in wheezy infants.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
07:15Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
Related Concept Videos
Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is important.
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...